COVID: FDA approves 1st emergency use of antibody drug (64)

The Mercury News 2020.11.10 04:16
An experimental treatment from Eli Lilly has been cleared for use Courtesy of Eli Lilly via AP On Monday the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. By The Associated Press | November 9, 2020 at 5:52 p.m. By Matthew Perrone | Associated Press WASHINGTON - U.S.
ANTIBODY, AUTHORIZATION, THERAPY, DRUG, DOSE, HOSPITALIZATION, Trump, Hughes, Regeneron Pharmaceuticals Inc., USA